Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| enterocyte | 7 studies | 39% ± 20% |
Insufficient scRNA-seq data for expression of GUCA2B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 75% | 57.87 | 170 / 226 | 59% | 14.85 | 238 / 406 |
| intestine | 63% | 1205.38 | 604 / 966 | 35% | 6.79 | 187 / 527 |
| stomach | 70% | 246.38 | 251 / 359 | 26% | 5.13 | 74 / 286 |
| kidney | 0% | 0 | 0 / 89 | 35% | 6.38 | 315 / 901 |
| pancreas | 7% | 1.98 | 24 / 328 | 26% | 1.90 | 46 / 178 |
| bladder | 0% | 0 | 0 / 21 | 16% | 2.47 | 82 / 504 |
| esophagus | 1% | 0.75 | 9 / 1445 | 9% | 0.66 | 17 / 183 |
| lung | 1% | 0.21 | 5 / 578 | 6% | 1.74 | 69 / 1155 |
| ovary | 0% | 0 | 0 / 180 | 5% | 0.34 | 20 / 430 |
| uterus | 0% | 0 | 0 / 170 | 4% | 0.82 | 18 / 459 |
| breast | 1% | 2.50 | 5 / 459 | 0% | 0.00 | 1 / 1118 |
| skin | 1% | 0.27 | 20 / 1809 | 0% | 0 | 0 / 472 |
| prostate | 1% | 0.22 | 2 / 245 | 0% | 0 | 0 / 502 |
| adrenal gland | 0% | 0 | 0 / 258 | 0% | 0.28 | 1 / 230 |
| peripheral blood | 0% | 0.09 | 4 / 929 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0.42 | 4 / 1204 | 0% | 0 | 0 / 0 |
| thymus | 0% | 0.04 | 1 / 653 | 0% | 0 | 0 / 605 |
| brain | 0% | 0.01 | 1 / 2642 | 0% | 0 | 0 / 705 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0019934 | Biological process | cGMP-mediated signaling |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005576 | Cellular component | extracellular region |
| GO_0030250 | Molecular function | guanylate cyclase activator activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | GUCA2B |
| Protein name | Guanylate cyclase activator 2B [Cleaved into: Guanylate cyclase C-activating peptide 2 (Guanylate cyclase C-activating peptide II) (GCAP-II); Uroguanylin (UGN)] |
| Synonyms | |
| Description | FUNCTION: Endogenous activator of intestinal guanylate cyclase. It stimulates this enzyme through the same receptor binding region as the heat-stable enterotoxins. May be a potent physiological regulator of intestinal fluid and electrolyte transport. May be an autocrine/paracrine regulator of intestinal salt and water transport. |
| Accessions | ENST00000372581.2 Q16661 |